“Turkish Validity and Reliability of the Temperature Sensitivity Scale for Individuals With Parkinson’s Disease”

by palligoelme@gmail.com | Jul 17, 2026 | Clinical Trials

​ Conditions: Parkinson Disease; Temperature Sensivity Sponsors: Acibadem University Recruiting Conditions: Parkinson Disease; Temperature Sensivity Sponsors: Acibadem University Recruiting 

Minimally Invasive Surgery for Spontaneous Deep Intracerebral Hemorrhage

by palligoelme@gmail.com | Jul 17, 2026 | Clinical Trials

​ Conditions: Intracerebral Hemorrhage; Spontaneous Intracerebral Hemorrhage; Basal Ganglia Hemorrhage Interventions: Procedure: Minimally Invasive Surgery (MIS); Other: Standard medical treatment (SMT) Sponsors: Tam Anh Research Institute; Tam Anh TP. Ho Chi Minh...

Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC

by palligoelme@gmail.com | Jul 17, 2026 | Clinical Trials

​ Conditions: Esophageal Squamous Cell Carcinoma (ESCC) Interventions: Drug: Sugemalimab and Chemotherapy; Drug: Nab-paclitaxel; Drug: Cisplatin; Radiation: Radiation Therapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not...

Effects of Shockwave Therapy Versus Ultrasound Therapy Among Patients With Chronic Sciatica

by palligoelme@gmail.com | Jul 17, 2026 | Clinical Trials

​ Conditions: Sciatica; Chronic Sciatica; Lumbar Radiculopathy Interventions: Device: Extracorporeal Shockwave Therapy; Device: Therapeutic Ultrasound; Other: Conventional Physiotherapy Sponsors: University of Lahore Completed Conditions: Sciatica; Chronic Sciatica;...

Identification of a Safe and Non-Psychedelic Dose of Psilocybin

by palligoelme@gmail.com | Jul 17, 2026 | Clinical Trials

​ Conditions: Healthy Controls Interventions: Drug: Psilocybin (low dose) or Placebo Sponsors: Diamond Therapeutics Inc.; BioPharma Services Inc. Completed Conditions: Healthy Controls Interventions: Drug: Psilocybin (low dose) or Placebo Sponsors: Diamond...

A Study Evaluating the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection

by palligoelme@gmail.com | Jul 17, 2026 | Clinical Trials

​ Conditions: Chronic Pain Interventions: Drug: KL0011034 injection; Drug: Alfentanil Hydrochloride Injection Sponsors: Hunan Kelun Pharmaceutical Co., Ltd. Not yet recruiting Conditions: Chronic Pain Interventions: Drug: KL0011034 injection; Drug: Alfentanil...